Article Versions Notes

Kumar P, Holland DA, Secrist K, Taskar P, Dotson B, Saleh-Birdjandi S, Adewunmi Y, Doering J, Mantis NJ, Volkin DB, et al. Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges. Vaccines. 2024; 12(6):609. https://doi.org/10.3390/vaccines12060609

Kumar, Prashant, David A. Holland, Kathryn Secrist, Poorva Taskar, Brandy Dotson, Soraia Saleh-Birdjandi, Yetunde Adewunmi, Jennifer Doering, Nicholas J. Mantis, David B. Volkin, and et al. 2024. "Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges" Vaccines 12, no. 6: 609. https://doi.org/10.3390/vaccines12060609

Kumar, P., Holland, D. A., Secrist, K., Taskar, P., Dotson, B., Saleh-Birdjandi, S., Adewunmi, Y., Doering, J., Mantis, N. J., Volkin, D. B., & Joshi, S. B. (2024). Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges. Vaccines, 12(6), 609. https://doi.org/10.3390/vaccines12060609